Daniel Häusermann

Daniel Häusermann specializes in public and private M&A, equity capital markets (ECM) and real estate transactions. He also advises on corporate and capital markets law and corporate governance. He has been partner at Homburger since 2021 and Co-head of the Healthcare/Life Sciences team since 2024. Daniel Häusermann is also a professor (Titularprofessor) of private and business law at the University of St. Gallen and has authored two books and over 40 articles. He regularly speaks at conferences in and outside Switzerland. 

• Advised Liberty Global and Sunrise on the spin-off of Sunrise and listing of Sunrise on the SIX and NASDAQ
• Advised Meyer Burger on its reverse share split
• Advised Santhera in connection with its up to CHF 69m royalty and debt Financing
• Advised ADC Therapeutics on its USD 105m underwritten offering of shares and pre-funded warrants
• Advised Meyer Burger on its CHF 206.75m rights offering
• Advised Novartis on the transfer of the Life Science Park Rhine Valley to Getec
• Advised Implenia on its acquisition of Wincasa
• Advised Migros on the reorganization of its supermarket business

• Capital markets: Equity
• M&A
• Private equity

• Consumer goods and services
• Healthcare
• Industrials
• Pharma and life sciences
• Tech and telecoms

• At all Swiss courts

• Swiss Bar Association
• Zurich Bar Association
• Chair of the Advisory Board, Capital Markets and Technology Association (CMTA)
• Sustaining Member, European Law Institute (ELI)

• Professor (Titularprofessor) of Private and Business Law, University of St. Gallen, Switzerland (2021)
• Private Reader (Privatdozent) for private and business law, University of St. Gallen (2015)
• LL.M., Harvard Law School (2011)
• Dr. iur., University of St. Gallen (2009)
• lic. iur. HSG, University of St. Gallen (2005)